Dainippon Sumotomo Unit To Offer $190 Million To Buy Elevation Pharma
This article was originally published in PharmAsia News
Executive Summary
A Dainippon Sumitomo unit said it would offer up to $190 million to buy Elevation Pharmaceuticals and its nasal allergy aerosol.